Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

[EX Q]: Business by its very nature is cut-throat; competitors rarely aid one another because one company's success almost invariably comes at the expense of the other's vitality. When such leg-ups occur, they are often inadvertent the result of one firm's having failed to take advantage of an opportunity that its competitor later cleaned up on. Such was the case when Mars, Inc. passed on the chance for its flagship product, M&Ms, to be the candy used in 1982 film E.T. the Extra-Terrestrial. Its turn-down cleared the way for Hershey Foods Corporation to make a remarkable splash for its Reese's Pieces. During production of E.T., Amblin Productions approached Mars, Inc. about a possible tie-in between M&Ms and the film. For whatever reason, Mars said "No" to the proposition. Many purported reasons for that negative response have been provided by a variety of sources: Mars decided it didn't want its bite-size candy associated with an extraterrestrial living with an earth family, or it thought the film's premise just a bit too otherworldly, or an unnamed M&M executive decided nobody would want to see a movie about an alien adopted by a lonely kid. (M&Ms did survive as the candy used in the 1982 William Kotzwinkle novelization of the film, however.) Lore adds its own details to flesh out stories, details that will cast the one who is perceived as having done something foolish in as absurd a light as possible. When that story is one of a poor business decision made by a large corporation, someone telling the tale is sure to state as rock-solid fact an explanation that is now clearly laughable. No one ever suggests that Mars might have already had its advertising budget locked for that year, or that it might have felt ill at ease at the prospect of dealing with a new advertising medium and the new people who went with it, or any other plausible and purely logical business reason for taking a pass on this offer. No, the "reason" offered in lore will always be something along the lines of "Mars didn't think much of the planned movie and thus wanted to keep themselves separate from it," a "reason" that casts the candymaker as unbelievably short-sighted given the breathtaking success of E.T. Whatever the reason for it, Mars' "No" paved the way for Hershey's "Yes." The spurned offer was then tendered to Hershey, and misgivings aside that corporation went for it. Hershey did not pay to have Reese's Pieces used in E.T., but it did agree to do a tie-in between the movie and the candy after the film was released. A deal was inked wherein Hershey Foods agreed to promote E.T. with $1 million of advertising; in return, Hershey could use E.T. in its own ads. Within two weeks of the movie's premiere, Reese's Pieces sales went through the roof. (Disagreement exists as to how far through the roof they went: Sales were variously described as having tripled, experienced an 85% jump, or increased by 65%). Whatever the numbers, though, Reese's Pieces up until then an underdog confection only faintly known by the U.S. candy-consuming public were suddenly being consumed in great handfuls. And all thanks to a shy little alien lured from the bushes and into America's hearts by a trail of peanut-butter-in-a-candy-coated-shell confections. Thus is the potential power of product placement. When it's done right, it can make a product. Paid product placement in films has come to be one of the ordinary ways of things in Hollywood. Exxon paid $300,000 for its name to appear in Days of Thunder, Pampers paid $50,000 to be featured in Three Men and a Baby, and Cuervo Gold spent $150,000 for placement in Tequila Sunrise, according to Danny Thompson, president of Creative Entertainment Services, in a 1993 New York magazine interview. As for how effective the practice of product placement is, that same article quotes Joel Henrie, a partner at Motion Picture Placement, as saying: "Look what happened to Hermes scarves after Basic Instinct, Ray-Ban sunglasses after Risky Business, and suspenders after Michael Douglas wore them in Wall Street." Not all product placement deals are "straight-fee" arrangements. There are actually three types of deals, the other two being the provision of costly merchandise (such as automobiles or appliances) for free just for the exposure (which accounts for about half of all placements), and the back-end promotion under which big corporations with huge promotional budgets aim for young audiences through tie-ins with popular films. In most films, product placement, while noticeable, is kept low-key. However, some Hollywood offerings have gone down in the annals of motion picture history as notorious examples of rampant commercialism. The 1988 snoozer Mac and Me could fairly be described as a ninety-minute advert for McDonald's and Coca-Cola, with an alien thrown in whenever things were running slow. Likewise, the 1987 film Leonard Part 6 was deemed by many to be a never-ending Coca-Cola commercial. But rampant product placement is not merely limited to forgettable films which did poorly at the box office, as 1999's Runaway Bride proved. (In that film, everyone walks around with a copy of USA Today in his hands.) Product placement in movies is now a corporate fact of life, as are "bonehead" accounts of great marketing opportunities left to the other guy. One company's gaffe becomes the cautionary tale passed along to those in all manner of industries because the message is universal: This could be us one day if we don't maintain vigilance. Once again, folklore is called upon to teach by example what might not have effectively been learned from a book. In an odd way, true-life corporate instances of one man's garbage turning out to be another man's treasure are almost a rip on the standard Hollywood legend of (pick your favorite movie star) was offered the lead in (now unforgettable, hugely-popular film) but turned it down. Though that scenario has indeed played out a number of times in Tinseltown, it hasn't happened nearly as often as is reported. In many cases, remembered tidbits of so-and-so's having been mentioned merely in passing at a studio round-table of "Who could we get?" are mentally embroidered into memories of the role's having been offered to the star, who waved it away. Or a bit of rumor is later remembered as fact, such as the case of Ronald Reagan, whose name was only kited as part of a press release designed to drum up interest in Casablanca but is now widely believed to have been the studio's first choice to play Rick Blaine a role never intended for anyone but Humphrey Bogart.
[EX A]: M&Ms passed up the chance to be the candy used to lure the shy little alien from his hiding place in the 1982 blockbuster E.T., thereby letting one of the most successful instances of movie product placement fall into the hands of a competitor who benefited mightily from it.

[EX Q]: "The article doesn't mention costs of angioplasty or costs of medications, which presumably must be taken for the rest of one's life. The article does mention that angioplasty is expensive, but does not provide real numbers or comparisons. The story provides absolute numbers of the primary endpoint over a 4-year period ""17 percent of those given angioplasty and drugs and nearly 16 percent of those given drugs alone had either died, suffered another heart attack or developed heart failure results considered to be statistically the same."" The story states that there was a worrisome trend toward more heart attacks in people who received late angioplasty compared to those who received just medications,although the story also tells readers that this could have been a statistical fluke or due to chance. However, other harms of the procedure were not discussed, including risks of the procedure itself, including bleeding, infection, or emotional distress/anxiety. The article also does not discuss risks of the alternative, e.g. medications, which have side effects, costs, or inconvenience. But, the story does discuss the main harm found in the study, e.g. a trend toward increased heart attacks. The research is important because it is a randomized controlled trial and the first such trial to be conducted for the clinical situation of late angioplasty in people with few to no symptoms after their heart attack. The story tells readers that enrollment of patients was delayed because ""doctors were unwilling to risk randomly assigning patients to drug treatment alone,"" indirectly stating that the study was a randomized trial. While an astute reader could probably pick up that this was a randomized trial, this fact could have been clearer. In addition, there islittlecontext around this being the first randomized trial for this clinical situation (as opposed to retrospective observational studies), although the story does tell readers that the results were surprising and that they could change guidelines. The story appropriately describes a heart attack, and more importantly, reinforces that early opening of the artery to restore blood flow to the heart after heart attack is still beneficial and that these results don't apply to that population or indeed the majority of people receiving angioplasties. No obvious disease mongering. The article provides an independent source of information from the chairman of theAmerican Heart Association program committee that reviewed the research. The story also provides information from the director of the National, Heart, Lung, and Blood Institute, but tells readers that this organization largely funded the research, therefore disclosing potential conflicts of interest. The story tells readers that the alternative that was tested in the latest research was medications, including those to lower blood pressure and cholesterol, aspirin, and anti-clotting drugs. The story could have mentioned beta-blockers specifically, since the protective effect of drug treatment may come from this family of drugs, although this is not yet proven. And the story could have been clearer about the course of treatment, e.g. that these medications are generally taken for the rest of one's life. The story tells readers that the usual treatment for people suffering a heart attackis angioplasty, even for a subset of people who weren't treated right away (the study population)/ The article also tells readers that the tendency to perform angioplasty electively (3 to 28 days after the event) was so strong, that recruitment to the study was prolonged in order to find enough patients (and their doctors) willing to participate in the study. It's widely understood that angioplasty and standard drug therapy after heart attackare not new. The article provides independent sources of information not included in the press release."
[EX A]: Study says late angioplasty futile

[EX Q]: The ALS Association funds one study that uses embryonic stem cell research, according to an August 23, 2014, article by the Minneapolis Star Tribune. The ALS Association said that the research was funded by "one specific donor who is committed to this area of research." Additionally, the ALS Association said donors were able to stipulate that they do not want their donations used to fund any stem cell research, if they so choose. Human embryonic stem cell lines that are used in research come from embryos that were left over from in vitro fertilization, or from embryos that carry genetic mutations like cystic fibrosis or Tay Sachs disease, according to the California Institute for Regenerative Medicine's website. After a couple completes the in vitro fertilization process, they either continue paying for the leftover embryos to remain frozen or allow them to thaw, which destroys the cells. Couples in some states, however, also have the choice to donate the embryos to research or adoptive families, according to the institute. "The discovery that human embryonic stem cells can be isolated and propagated in culture with the potential of developing into all tissues of the body is a major medical breakthrough. However it has raised a great deal of ethical questions," the ALS Association said on its website. Posted08/25/14 Comments
[EX A]:
Religious groups have raised concerns that the ALS Association, which has seen an overwhelming influx of donations through its ice bucket challenge, supports embryonic stem cell research to help find a cure for the degenerative neurological condition.